You have successfully logged out.

Hello !
Logout

Intrafix® SafeSet Flush

Total prescribed dose delivery

Intrafix® SafeSet Flush combines a Caresite® needlefree injection port with AirStop technology, allowing post-medication flushing via a syringe. This ensures complete delivery of the prescribed medication, minimising the risk of underdosing.

Underdosing

  • Due to residual volume in the administration set line, up to

    0%

    of the active prescribed drug may not be administered1

Intrafix® SafeSet Flush
Untitled (800 x 450 px) - 8
Order samples

Flushing residual volume

Access the Caresite® needlefree valve using a small volume syringe, enabling the residual volume of the drug to be infused without the risk of overloading the patient with fluid.

/

AirStop

AirStop technology helps prevent air entering the line enabling flushing of the residual volume of the drug.

/

Waste reduction

Flushing the line helps avoid unnecessary antibiotic waste and minimises environmental exposure from discarded administration sets containing residual medication.

/

Cost reduction

Flushing the line helps prevent costly drug wastage7

/

Reducing infections

A closed system can be maintained, reducing the risk of infection.

/

How does underdosing occur? 

safeset-applied-to-patient.jpg

What are the implications of underdosing?

Clinical demonstration videos

Scientific evidence & webinars

Research and guidance

  • Antibiotic underdosing and disposal in NHS organisations across Great Britain

    Research Report & Policy Brief

    pdf, 1.5 MB

  • Antimicrobial Stewardship & Patient Safety Improvements

    Clare Goodyear – Salisbury NHS Foundation Trust

    pdf, 615.2 KB

  • Antimicrobial Stewardship in OPAT

    Laura Maclachlan – Hull University Teaching Hospitals NHS Trust

    pdf, 842.3 KB

  • Non-flushing of IV administration sets: an under-recognised under-dosing risk.

    Dawn Michelle Cooper, Thomas Rassam, Adrian Mellor

    link

check_circle

Your request could not be submitted. Please try again.

warning

Related Documents

1. Santillo, M (2022) IV Forum; Advancements in IV Administration,

https://www.youtube.com/watch?v=0WAupmxRDTY

2. Cooper DM, Rassam T, Mellor A. Non-flushing of IV administration sets: an under-recognised under-dosing risk. Br J Nurs. 2018 Jul 26;27(14):S4-S12. doi: 10.12968/bjon.2018.27.14.S4. PMID: 30048183.

3. Harding M, Stefka S, Bailey M, Morgan D, Anderson A. Best Practice for Delivering Small-Volume Intermittent Intravenous Infusions. J Infus Nurs. 2020 Jan/Feb;43(1):47-52. doi: 10.1097/NAN.0000000000000355. PMID: 31876774.

4. Roseau JB, Pradines B, Paleiron N, Vedy S, Madamet M, Simon F, Javelle E. Failure of dihydroartemisinin plus piperaquine treatment of falciparum malaria by under-dosing in an overweight patient. Malar J. 2016 Sep 20;15:479. doi: 10.1186/s12936-016-1535-8. PMID: 27646822; PMCID: PMC5028982.

5. National Infusion & Vascular Access Society, Intravenous Administration of Medicines to Adults: Guidance on ‘Line Flushing’, version 3, 2021

6. Barton, A (2022) Line Flushing – Changing the way we do things, presented at Infection Prevention Society IV Forum Conference, https://www.youtube.com/watch?v=eEOeYVjru00

7. Goodyear, C (2022) Poster presentation at the National Infusion and Vascular Access Society Conference, Antimicrobial Stewardship & Patient Safety Improvements: Introducing the NIVAS Line Flushing Guidance